<DOC>
	<DOCNO>NCT02542969</DOCNO>
	<brief_summary>The purpose study determine whether MGL-3196 alters pharmacokinetics rosuvastatin and/or simvastatin healthy male subject female subject child-bearing potential .</brief_summary>
	<brief_title>Drug Interaction Study MGL-3196 With Rosuvastatin Simvastatin</brief_title>
	<detailed_description />
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Must willing able provide write informed consent . Healthy , nonsmoking , male female age 18 55 year ( inclusive ) . Body weight &gt; 50 kg BMI 18 32 kg/m2 ( inclusive ) . If female , nonchild bear potential ( i.e. , surgically [ bilateral oophorectomy , hysterectomy , hysteroscopic sterilization , tubal ligation ] . Or , naturally sterile [ &gt; 12 consecutive month without menses ] ) verification follicle stimulate hormone ( FSH ) screening . If male nonvasectomized , must agree use condom spermicide abstain sexual intercourse study 30 day beyond last dose study drug . No restriction require vasectomized male provide vasectomy perform 4 month prior first dose study drug . A male vasectomized less 4 month prior study start must follow procedure nonvasectomized male . Any clinically significant abnormal finding physical examination include blood pressure , heart rate rhythm , clinical laboratory test 12lead ECG . Evidence history clinically significant hematological , endocrine , pulmonary , gastrointestinal , cardiovascular , renal , hepatic , neurological psychiatric disease . Thyroid stimulate hormone test screen outside normal range . Repeat test allow discretion Investigator . Current recent ( &lt; 6 month ) hepatobiliary disease ; aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) direct bilirubin great upper limit reference range screening . Repeat test allow discretion Investigator . Elevated creatine kinase ( CK ) screening ( one repeat test allow ) . Gilbert 's syndrome . Positive screen test HIV antibody , Hepatitis B surface antigen Hepatitis C antibody . Abnormal screen ECG : include machineread QTc &gt; 450 msec ( confirm manual read ) , QRS &gt; 110 msec , intermittent bundle branch block , frequent premature atrial premature ventricular contraction , rhythm normal sinus rhythm interpret Investigator clinically significant . History sensitivity similar study drug ( e.g. , Karo Bio KB2115 Metabasis MB7811 ) , history important drug allergy ( except untreated , asymptomatic seasonal allergy time dose ) unless deem clinically significant Investigator . History sensitivity thyroid medication . History intolerance adverse reaction statin , history myopathy include rhabdomyolysis . Intolerance betablockers ( betablocker treatment could appropriate alleviate tachycardia observe ) . Participation another clinical trial investigational drug ( medical device ) within last 30 day prior first dose day , expose four new chemical entity within 12 month prior first dose day . Use St. John 's Wort within 28 day first dose study drug . Unwilling forgo consumption red wine , Seville oranges , grapefruit grapefruit juice and/or pomelo , star fruit , grapefruit hybrid citrus juice 5 day prior first dose study drug throughout study . Subjects history drug alcohol abuse define Diagnostic Statistical Manual 5th Edition . History regular alcohol consumption exceed 7 drinks/week female 14 drinks/week men ( 1 drink = 5 ounce wine 12 ounce beer 1.5 ounce hard liquor ) within 6 month prior screen . Use acetaminophen within 7 day dose throughout study except treatment adverse event direct Investigator . History regular use tobacco nicotine containing product within past 6 month relative screening . Positive urine drug screen alcohol test screen Day 1 . Women pregnant may become pregnant , nursing . Strenuous physical activity could cause muscle ache injury , include contact sport , time 3 day prior first dose study drug completion study . Excessive caffeine intake ( &gt; 3 cup coffee/day equivalent ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>